The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 10, 2023
Filed:
Jun. 29, 2022
Applicant:
Immatics Biotechnologies Gmbh, Tuebingen, DE;
Inventors:
Toni Weinschenk, Tuebingen, DE;
Andrea Mahr, Tuebingen, DE;
Jens Fritsche, Tuebingen, DE;
Phillip Mueller, Tuebingen, DE;
Anita Wiebe, Tuebingen, DE;
Sarah Kutscher, Tuebingen, DE;
Assignee:
IMMATICS BIOTECHNOLOGIES GMBH, Tuebingen, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 7/00 (2006.01); A61K 35/17 (2015.01); A61K 39/00 (2006.01); A61K 38/04 (2006.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01); C07K 14/435 (2006.01); C07K 14/725 (2006.01); C07K 14/74 (2006.01); C07K 16/18 (2006.01); C12N 5/0783 (2010.01); C12N 15/115 (2010.01); G01N 33/68 (2006.01); A61K 51/10 (2006.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
A61K 39/00111 (2018.08); A61K 35/17 (2013.01); A61K 38/04 (2013.01); A61K 39/0011 (2013.01); A61K 51/1057 (2013.01); C07K 7/00 (2013.01); C07K 7/06 (2013.01); C07K 7/08 (2013.01); C07K 14/435 (2013.01); C07K 14/7051 (2013.01); C07K 14/70539 (2013.01); C07K 16/18 (2013.01); C12N 5/0636 (2013.01); C12N 15/115 (2013.01); G01N 33/6803 (2013.01); A61K 2035/124 (2013.01); A61K 2039/5154 (2013.01); A61K 2039/5158 (2013.01); C07K 2317/70 (2013.01); C07K 2319/40 (2013.01); C12N 2310/16 (2013.01); C12N 2501/998 (2013.01);
Abstract
A method of eliciting an immune response in a patient who has a cancer includes administering to said patient a composition containing a population of activated T cells that selectively recognize the cancer cells in the patient that aberrantly express a peptide consisting of the amino acid sequence of IYVTSIEQI (SEQ ID NO: 214), in which the peptide is in a complex with an MHC molecule.